You are here

  • Home
  • Archive
  • Volume 4, Issue 1
  • Mental health, fatigue and function are associated with increased risk of disease flare following TNF inhibitor tapering in patients with rheumatoid arthritis: an exploratory analysis of data from the Optimizing TNF Tapering in RA (OPTTIRA) trial

Article metrics

Article menu

Download PDFPDF

Rheumatoid arthritis
Original article
Mental health, fatigue and function are associated with increased risk of disease flare following TNF inhibitor tapering in patients with rheumatoid arthritis: an exploratory analysis of data from the Optimizing TNF Tapering in RA (OPTTIRA) trial

 

Online download statistics by month:

Online download statistics by month: May 2018 to March 2024

AbstractFullPdf
May 201821822549
Jun 201817717738
Jul 201868687
Aug 201833338
Sep 201822225
Oct 2018272710
Nov 201823236
Dec 201823238
Jan 2019322610
Feb 201920145
Mar 201938365
Apr 201935236
May 2019484617
Jun 201947447
Jul 2019373512
Aug 201942426
Sep 2019363512
Oct 2019383716
Nov 2019433817
Dec 2019454418
Jan 202062617
Feb 2020474712
Mar 202053536
Apr 202029297
May 202033346
Jun 2020151411
Jul 202032232111
Aug 20202542508
Sep 2020989713
Oct 2020322726
Nov 202044329
Dec 202050389
Jan 202132289
Feb 202125238
Mar 2021362817
Apr 202134319
May 2021333311
Jun 2021312710
Jul 2021232015
Aug 202121186
Sep 202120198
Oct 2021211922
Nov 202110813
Dec 2021222217
Jan 202236319
Feb 202234356
Mar 2022333211
Apr 2022272810
May 2022525717
Jun 202241397
Jul 202253493
Aug 202251467
Sep 2022514719
Oct 2022292510
Nov 2022191711
Dec 202216143
Jan 2023212311
Feb 202343398
Mar 202328307
Apr 202319186
May 202312129
Jun 202317145
Jul 202321169
Aug 2023151518
Sep 2023191715
Oct 2023272710
Nov 202340366
Dec 202331245
Jan 2024775
Feb 202414135
Mar 2024231613
Total31783024777